CRISPR Technology

Global CRISPR Technology Market to Reach US$10.6 Billion by 2030

The global market for CRISPR Technology estimated at US$2.8 Billion in the year 2023, is expected to reach US$10.6 Billion by 2030, growing at a CAGR of 21.1% over the analysis period 2023-2030. Products Component, one of the segments analyzed in the report, is expected to record a 20.3% CAGR and reach US$6.1 Billion by the end of the analysis period. Growth in the Services Component segment is estimated at 22.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$794.2 Million While China is Forecast to Grow at 20.4% CAGR

The CRISPR Technology market in the U.S. is estimated at US$794.2 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 20.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.1% and 17.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.9% CAGR.

Global CRISPR Technology Market – Key Trends & Drivers Summarized

What Is CRISPR Technology and How Does It Work in Gene Editing?

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is a groundbreaking gene-editing tool that allows scientists to precisely modify DNA sequences in living organisms. Originally discovered as a natural defense mechanism in bacteria, CRISPR has been adapted into a powerful genetic engineering technique by utilizing the Cas9 protein (an enzyme) to target and cut specific DNA strands. This "cut and paste" capability enables researchers to add, remove, or alter genetic material at precise locations within the genome, revolutionizing fields such as biotechnology, agriculture, and medicine. The technology works by guiding the Cas9 enzyme to a targeted DNA sequence, where it makes a precise cut, enabling the insertion of new genes or repair of existing ones. This specificity allows for efficient, targeted editing with fewer off-target effects than traditional methods.

CRISPR`s ability to edit genes accurately and affordably has immense implications, from treating genetic disorders to creating genetically modified crops with enhanced resilience. By allowing scientists to directly manipulate genes responsible for diseases, CRISPR technology holds the promise of addressing conditions that were previously thought to be incurable. In agriculture, CRISPR is being used to develop crops that are more nutritious, resistant to pests, and adaptable to climate change. As CRISPR technology advances, its applications are expanding rapidly, positioning it as a vital tool across multiple industries. This precision, efficiency, and versatility have made CRISPR one of the most transformative technologies of our time.

How Are Technological Advancements Driving Innovation in CRISPR?

Technological advancements are continuously refining CRISPR technology, enhancing its precision, efficiency, and applicability in various fields. One of the key developments has been the evolution of Cas proteins beyond Cas9, including Cas12 and Cas13, which target different types of genetic material (like RNA) and expand the versatility of CRISPR applications. These alternative enzymes allow for more specific targeting and reduce off-target effects, which is crucial for therapeutic applications in humans. Additionally, base editing and prime editing have emerged as new techniques within the CRISPR framework, allowing for single base pair changes and more precise DNA modifications without making double-stranded breaks. These innovations open the door to more complex genetic editing, including the potential to correct single mutations that cause genetic disorders.

Bioinformatics and artificial intelligence are further driving CRISPR advancements by enabling researchers to predict off-target effects and design more accurate guide RNAs for targeting specific genes. Machine learning models help identify potential off-target sites and improve the precision of gene editing, which is particularly important in therapeutic applications where accuracy is paramount. Advances in delivery methods, such as viral vectors, nanoparticles, and lipid-based carriers, have also improved the ability to introduce CRISPR components into cells efficiently, expanding the technology’s reach into in vivo applications. These advancements make CRISPR more accessible and safe, paving the way for its application in human gene therapy, agriculture, and synthetic biology.

Why Are There Ethical and Regulatory Challenges Surrounding CRISPR Technology?

While CRISPR offers immense potential, it raises significant ethical and regulatory challenges, particularly around human gene editing. The ability to alter the human genome, especially in germline cells (which are passed on to future generations), has sparked a global debate on the ethics of gene editing. There are concerns that gene editing could lead to “designer babies,” where genetic traits like intelligence or physical appearance might be altered, leading to social inequality and potential misuse. Additionally, the long-term effects of germline editing are still unknown, raising questions about the risks associated with inheritable genetic changes. These ethical concerns have prompted regulatory bodies worldwide to impose strict guidelines and, in some cases, outright bans on germline editing, even as they encourage research in non-heritable (somatic) gene editing for therapeutic purposes.

Regulatory frameworks for CRISPR technology vary widely by region, adding complexity to its global development and application. In the United States, the FDA regulates gene editing applications in human therapeutics, while the USDA and EPA govern its use in agriculture. The European Union has adopted stringent regulations, particularly around genetically modified organisms (GMOs), which affects CRISPR applications in agriculture. Additionally, there is a need for clear guidelines to ensure patient safety and prevent off-target effects when CRISPR is used in clinical settings. The rapid advancement of CRISPR technology has outpaced regulatory frameworks in many regions, leading to calls for updated, globally coordinated policies that balance innovation with ethical considerations. Addressing these challenges is crucial for the responsible development and acceptance of CRISPR technology in society.

What Factors Are Driving Growth in the CRISPR Technology Market?

The growth in the CRISPR technology market is driven by a combination of scientific advancements, expanding applications across industries, and increasing investments in genetic research. The technology’s potential to treat genetic disorders, develop targeted therapies for cancer, and create disease-resistant crops has attracted significant interest from pharmaceutical companies, agricultural firms, and research institutions. Investments in CRISPR research and development have surged, with private and public funding fueling advancements and accelerating the commercialization of CRISPR-based solutions. The biopharmaceutical industry, in particular, is investing heavily in CRISPR for drug discovery, gene therapies, and personalized medicine, where precise gene editing can tailor treatments to individual patients’ genetic profiles.

In agriculture, CRISPR is being used to create crops with improved nutritional profiles, pest resistance, and climate resilience, addressing the need for sustainable food production as the global population grows. This agricultural application has gained traction as environmental concerns prompt a shift toward eco-friendly and efficient farming practices. Additionally, the CRISPR market benefits from technological advancements in gene editing tools, bioinformatics, and delivery methods, which make CRISPR more accessible and applicable in various research and clinical settings. Together, these factors are propelling the growth of the CRISPR technology market, positioning it as a transformative force in both the life sciences and agricultural sectors. As research progresses and regulatory frameworks evolve, CRISPR’s applications are expected to expand further, supporting continued market growth.

Select Competitors (Total 34 Featured) -
  • Agilent Technologies
  • Cellecta, Inc.
  • GeneCopoeia, Inc.
  • GenScript
  • Horizon Discovery Group
  • Integrated DNA Technologies (IDT)
  • Merck KGaA
  • New England Biolabs
  • Origene Technologies, Inc.
  • Synthego Corporation
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
CRISPR Technology – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Demand for Precision Gene Editing in Agriculture and Healthcare Spurs Growth in CRISPR Technology Market
Rising Incidence of Genetic Disorders and Rare Diseases Drives Research and Development in CRISPR-Based Therapeutics
Expanding Applications of CRISPR in Gene Therapy Propels Demand for Advanced Genome Editing Solutions
Development of CRISPR-Based Diagnostics Expands Addressable Market Beyond Therapeutics to Include Early Disease Detection
Advancements in Delivery Mechanisms and Targeting Techniques Strengthen CRISPRs Potential in Therapeutic Applications
Growth in Funding and Investments from Public and Private Sectors Drives Innovation and Commercialization of CRISPR Solutions
Increasing Use of CRISPR in Agricultural Biotechnology Expands Market for Genetically Enhanced Crops with Improved Yield and Resistance
Rising Demand for Livestock Genetic Modification Strengthens Market Opportunities for CRISPR in Animal Health
Expansion of Personalized Medicine and Targeted Therapies Supports Growth of CRISPR in Precision Healthcare
Development of CRISPR Platforms for Functional Genomics Research Accelerates Drug Discovery and Biomedical Research
Increasing Adoption of CRISPR in Synthetic Biology Drives Development of Industrial Microbial Strains and Bio-Manufacturing Applications
Demand for Improved Crop Varieties Amid Climate Change Propels Market for CRISPR Technology in Sustainable Agriculture
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for CRISPR Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for CRISPR Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for CRISPR Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Biomedical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Biomedical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Biomedical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Agricultural by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for Agricultural by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for Agricultural by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 29: World Historic Review for Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 30: World 16-Year Perspective for Industrial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 31: World Recent Past, Current & Future Analysis for Biological Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 32: World Historic Review for Biological Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 33: World 16-Year Perspective for Biological Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 34: World CRISPR Technology Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
CRISPR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 35: USA Recent Past, Current & Future Analysis for CRISPR Technology by Component - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for CRISPR Technology by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for CRISPR Technology by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for CRISPR Technology by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: USA Historic Review for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: USA 16-Year Perspective for CRISPR Technology by Application - Percentage Breakdown of Value Sales for Biomedical, Agricultural, Industrial and Biological Research for the Years 2014, 2024 & 2030
CANADA
TABLE 44: Canada Recent Past, Current & Future Analysis for CRISPR Technology by Component - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for CRISPR Technology by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for CRISPR Technology by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 47: Canada Recent Past, Current & Future Analysis for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: Canada Historic Review for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Canada 16-Year Perspective for CRISPR Technology by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Canada Historic Review for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Canada 16-Year Perspective for CRISPR Technology by Application - Percentage Breakdown of Value Sales for Biomedical, Agricultural, Industrial and Biological Research for the Years 2014, 2024 & 2030
JAPAN
CRISPR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 53: Japan Recent Past, Current & Future Analysis for CRISPR Technology by Component - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: Japan Historic Review for CRISPR Technology by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Japan 16-Year Perspective for CRISPR Technology by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 56: Japan Recent Past, Current & Future Analysis for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: Japan Historic Review for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: Japan 16-Year Perspective for CRISPR Technology by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Japan Historic Review for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Japan 16-Year Perspective for CRISPR Technology by Application - Percentage Breakdown of Value Sales for Biomedical, Agricultural, Industrial and Biological Research for the Years 2014, 2024 & 2030
CHINA
CRISPR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 62: China Recent Past, Current & Future Analysis for CRISPR Technology by Component - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: China Historic Review for CRISPR Technology by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: China 16-Year Perspective for CRISPR Technology by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 65: China Recent Past, Current & Future Analysis for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: China Historic Review for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: China 16-Year Perspective for CRISPR Technology by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: China Historic Review for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: China 16-Year Perspective for CRISPR Technology by Application - Percentage Breakdown of Value Sales for Biomedical, Agricultural, Industrial and Biological Research for the Years 2014, 2024 & 2030
EUROPE
CRISPR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 71: Europe Recent Past, Current & Future Analysis for CRISPR Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 72: Europe Historic Review for CRISPR Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Europe 16-Year Perspective for CRISPR Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for CRISPR Technology by Component - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for CRISPR Technology by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for CRISPR Technology by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Europe Historic Review for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Europe 16-Year Perspective for CRISPR Technology by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Europe Historic Review for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Europe 16-Year Perspective for CRISPR Technology by Application - Percentage Breakdown of Value Sales for Biomedical, Agricultural, Industrial and Biological Research for the Years 2014, 2024 & 2030
FRANCE
CRISPR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 83: France Recent Past, Current & Future Analysis for CRISPR Technology by Component - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: France Historic Review for CRISPR Technology by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: France 16-Year Perspective for CRISPR Technology by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 86: France Recent Past, Current & Future Analysis for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: France Historic Review for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: France 16-Year Perspective for CRISPR Technology by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: France Historic Review for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: France 16-Year Perspective for CRISPR Technology by Application - Percentage Breakdown of Value Sales for Biomedical, Agricultural, Industrial and Biological Research for the Years 2014, 2024 & 2030
GERMANY
CRISPR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 92: Germany Recent Past, Current & Future Analysis for CRISPR Technology by Component - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Germany Historic Review for CRISPR Technology by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Germany 16-Year Perspective for CRISPR Technology by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 95: Germany Recent Past, Current & Future Analysis for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Germany Historic Review for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Germany 16-Year Perspective for CRISPR Technology by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Germany Historic Review for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Germany 16-Year Perspective for CRISPR Technology by Application - Percentage Breakdown of Value Sales for Biomedical, Agricultural, Industrial and Biological Research for the Years 2014, 2024 & 2030
ITALY
TABLE 101: Italy Recent Past, Current & Future Analysis for CRISPR Technology by Component - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Italy Historic Review for CRISPR Technology by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Italy 16-Year Perspective for CRISPR Technology by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 104: Italy Recent Past, Current & Future Analysis for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Italy Historic Review for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Italy 16-Year Perspective for CRISPR Technology by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 107: Italy Recent Past, Current & Future Analysis for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Italy Historic Review for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Italy 16-Year Perspective for CRISPR Technology by Application - Percentage Breakdown of Value Sales for Biomedical, Agricultural, Industrial and Biological Research for the Years 2014, 2024 & 2030
UNITED KINGDOM
CRISPR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 110: UK Recent Past, Current & Future Analysis for CRISPR Technology by Component - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: UK Historic Review for CRISPR Technology by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: UK 16-Year Perspective for CRISPR Technology by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 113: UK Recent Past, Current & Future Analysis for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: UK Historic Review for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: UK 16-Year Perspective for CRISPR Technology by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: UK Historic Review for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: UK 16-Year Perspective for CRISPR Technology by Application - Percentage Breakdown of Value Sales for Biomedical, Agricultural, Industrial and Biological Research for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for CRISPR Technology by Component - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: Rest of Europe Historic Review for CRISPR Technology by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: Rest of Europe 16-Year Perspective for CRISPR Technology by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: Rest of Europe Historic Review for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: Rest of Europe 16-Year Perspective for CRISPR Technology by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Europe Historic Review for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Europe 16-Year Perspective for CRISPR Technology by Application - Percentage Breakdown of Value Sales for Biomedical, Agricultural, Industrial and Biological Research for the Years 2014, 2024 & 2030
ASIA-PACIFIC
CRISPR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for CRISPR Technology by Component - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: Asia-Pacific Historic Review for CRISPR Technology by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: Asia-Pacific 16-Year Perspective for CRISPR Technology by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 132: Asia-Pacific Historic Review for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Asia-Pacific 16-Year Perspective for CRISPR Technology by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Asia-Pacific Historic Review for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Asia-Pacific 16-Year Perspective for CRISPR Technology by Application - Percentage Breakdown of Value Sales for Biomedical, Agricultural, Industrial and Biological Research for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 137: Rest of World Recent Past, Current & Future Analysis for CRISPR Technology by Component - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of World Historic Review for CRISPR Technology by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of World 16-Year Perspective for CRISPR Technology by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 140: Rest of World Recent Past, Current & Future Analysis for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Rest of World Historic Review for CRISPR Technology by End-Use - Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Rest of World 16-Year Perspective for CRISPR Technology by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations, Pharma & Biopharma Companies, Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
TABLE 143: Rest of World Recent Past, Current & Future Analysis for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Rest of World Historic Review for CRISPR Technology by Application - Biomedical, Agricultural, Industrial and Biological Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Rest of World 16-Year Perspective for CRISPR Technology by Application - Percentage Breakdown of Value Sales for Biomedical, Agricultural, Industrial and Biological Research for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings